Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation

Size: px
Start display at page:

Download "Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation"

Transcription

1 JOURNAL OF VIROLOGY, Sept. 2005, p Vol. 79, No X/05/$ doi: /jvi Copyright 2005, American Society for Microbiology. All Rights Reserved. Influence of Fiber Detargeting on Adenovirus-Mediated Innate and Adaptive Immune Activation John W. Schoggins, 1 Marcelo Nociari, 1 Nicola Philpott, 2 and Erik Falck-Pedersen 1 * Weill Medical College of Cornell University, Hearst Research Foundation, Department of Microbiology and Immunology, Molecular Biology Graduate Program, New York, New York 10021, 1 and Molecular Immunology Unit, Institute of Child Health, 30 Guilford Street, University College London, WC1N 1EH, United Kingdom 2 Received 2 March 2005/Accepted 28 June 2005 The major adenovirus (Ad) capsid proteins hexon, penton, and fiber influence the efficiency and tropism of gene transduction by Ad vectors. Fiber is the high-affinity receptor binding protein that serves to mediate cell attachment in vitro when using coxsackie-adenovirus receptor (CAR)-containing cell lines. This contrasts with transduction efficiency in macrophages or dendritic cells that lack high concentrations of CAR. To determine how fiber influences gene transduction and immune activation in a murine model, we have characterized Ad type 5 (Ad5) vectors with two classes of chimeric fiber, CAR binding and non-car binding. In a systemic infection, Ad5 fiber contributes to DNA localization and vector transduction in hepatic tissue. However, the majority of vector localization is due to Ad5 fiber-specific functions distinct from CAR binding. CAR-directed transduction occurs but at a modest level. In contrast to CAR binding vectors, the F7 and F7F41S non-carbinding vectors demonstrate a 2-log decrease in hepatic transduction, with a 10-fold decrease in the amount of vector DNA localizing to the hepatic tissue. To characterize the innate response to early infection using fiber chimeric vectors, intrahepatic cytokine and chemokine mrnas were quantified 5 hours postinfection. Tumor necrosis factor alpha mrna levels resulting from Ad5 fiber infections were elevated compared to viruses expressing serotype 7 or 41 fiber. Levels of chemokine mrna (gamma interferon-inducible protein 10, T-cell activation gene 3, and macrophage inflammatory protein 1 ) were 10- to 20-fold higher with CAR binding vectors (Ad5 and F41T) than with non-car-binding vectors (F7 and F7F41S). In spite of quantitative differences in vector localization and innate activation, fiber pseudotyping did not significantly change the outcome of anti-ad adaptive immunity. All vectors were cleared with the same kinetics as wild-type Ad5 vectors, and each induced neutralizing antibody. Although non-car-binding vectors were impaired in transduction by nearly 2 orders of magnitude, the level of antitransgene immunity was the same for each of the vectors. Using primary bone marrow-derived macrophages and dendritic cells, we demonstrate that transduction, induction of cytokine/chemokine, and phenotypic maturation of these antigen-presenting cells are independent of fiber content. Our data support a model where fiber-mediated hepatic localization enhances innate responses to virus infection but minimally impacts on adaptive immunity. Studies using adenovirus (Ad) vectors have provided insight into the major problems that must be addressed when considering viral vectors for gene therapy applications. Issues confronting the use of Ad vectors include the innate and adaptive antiviral immune response, the lack of cell- or tissue-specific targeting, and the need to establish stable long-term gene expression. The Ad capsid plays a major role in two of these issues, tissue-specific targeting and stimulation of the antiviral innate and adaptive immune response. Therefore, efforts to manipulate the viral capsid structure offer an opportunity to control vector targeting as well as influence immune activation. Three major protein components of the Ad capsid include the structural proteins hexon, penton base, and fiber. Hexon is the main structural element forming the body of the capsid. Penton base and fiber form the structural unit penton, located at each of the 12 vertices of the icosahedral capsid. The capsid proteins are responsible for efficient gene transduction by adenovirus vectors. Adenovirus type 5 (Ad5) uptake into human * Corresponding author. Mailing address: Weill Medical College of Cornell University, Department of Microbiology and Immunology, Box 62, 1300 York Ave., New York, New York Phone: (212) Fax: (212) efalckp@med.cornell.edu. cell lines occurs through a multistep process that first relies on high-affinity binding of fiber to a cell surface receptor. For the majority of Ad serotypes, fiber binds to the cell surface protein coxsackie-adenovirus receptor (CAR) (1, 2, 19, 28), which is expressed in a variety of tissue types (27). Following fiber/car complex formation, penton base binds to v integrins and stimulates endocytosis of viral particles (30). In the absence of fiber-mediated high-affinity binding, transduction can still occur but at significantly reduced levels. How Ad5 recognizes and binds cells in the absence of a fiber-directed pathway is not well understood. Penton base binding to v integrins may contribute to the low efficiency uptake of Ad5 vectors in cells that lack CAR (8). Other nonspecific mechanisms such as phagocytosis and macropinocytosis may be used in certain cell types. In contrast to in vitro studies of Ad infection, in vivo applications of Ad5-based vectors have revealed a more complex biology of virus-cell interactions that influence gene transduction. Following systemic administration in a murine model, greater than 90% of an Ad5-based vector localizes to the liver (32). However, the majority of virus localized to the liver within the first hours postinfection does not contribute to hepatocyte transduction and is eliminated within 24 h of administration. For the small fraction of Ad5 vector that successfully 11627

2 11628 SCHOGGINS ET AL. J. VIROL. transduces hepatic tissue, the role of high-affinity fiber/car binding is surprisingly small. Depending on the study and vector used, between 10 and 50% of intrahepatic transduction occurs in a fiber/car-dependent manner (4, 11, 13, 24). It has been proposed that Ad5 fiber binding to heparan sulfate glycosaminoglycans (HSG) (3, 16, 26) plays an important role in intrahepatic localization as well as transduction following systemic administration of vector in a murine model. The vast majority of Ad5 vector that localizes to the liver is rapidly eliminated. Kupffer cells are the predominant macrophages of liver, and studies have demonstrated that Kupffer cell depletion impacts on viral localization and transduction (12, 32). Macrophages and other cells of the immune system take up Ad5-based vectors, but these cells often lack CAR and transduction is generally very inefficient (8). Recognition of virus by these cells results in vector clearance and contributes to both the inflammatory and the antiviral adaptive immune responses that arise following exposure to virus (34). For Ad5 vectors, the strong inflammatory response and the antiviral adaptive immune response are major impediments for gene therapy applications but potential assets for anticancer or vaccine applications. These studies highlight both the importance of understanding the complex binding interactions that take place in a systemic infection with Ad vectors and the need to develop effective Ad detargeting strategies. Several Ad5-based vectors that demonstrate a decreased transduction phenotype in vivo have been constructed. Mutations in Ad5 fiber that abolish CAR binding have been combined with mutations in putative HSG binding domains (16, 25), resulting in diminished liver transduction following systemic administration. Another approach to detargeting Ad5- based vectors has been to replace Ad5 fiber with a fiber moiety from a non-car-binding virus. There are several classes of non-car-binding Ad fibers. One is the subgroup B class of virus. Recent studies have demonstrated that human CD46 serves as a target receptor for many of the subgroup B viruses (5, 21, 23). A variety of human cell lines express the subgroup B receptors and are efficiently infected by subgroup B vectors or Ad5 vectors pseudotyped with a subgroup B fiber (5, 21). Important to this study, the CD46 receptor is not abundantly expressed in murine tissues, making a subgroup B fiber-containing vector potentially detargeted in a mouse model (5). A second class of non-car-binding fiber is derived from the subgroup F adenoviruses. The subgroup F viruses express two fiber genes tandemly arranged (10): a long-shafted fiber that binds CAR and a short-shafted fiber that has no known binding function (19). Recent studies using Ad5 vectors pseudotyped with subgroup F short fiber demonstrate reduced transduction of hepatic tissue following a systemic administration of vector (15, 16, 20). In the current study we have examined the biology of fibermodified viruses with respect to viral transduction, viral DNA localization, and the influence on innate and adaptive immune responses to Ad5-based fiber detargeted vectors. We have found that, in Ad5-based vectors, fiber-mediated transduction and localization to liver contribute to a heightened early innate response as determined by induction of chemokine and cytokine mrnas. In comparison, non-car-binding vectors exhibit reduced localization to the liver, reduced gene transduction, and diminished induction of mrna associated with activation of the inflammatory response. In spite of these beneficial detargeting characteristics, the adaptive arm of the immune system is largely unaffected by these capsid modifications. MATERIALS AND METHODS Adenovirus vector stocks and cell lines. Four E1/E3-deleted Ad5-based vectors were used in this study: Ad5, F7, F7F41S, and F41T. Construction and characterization of these vectors have been described in detail elsewhere (20). The F7 vector was generated by genetically swapping the fiber 5 coding region of Ad5 with the entire fiber gene from Ad serotype 7. The F7F41S vector genome contains coding regions from both fiber 7 and the short-shafted fiber from Ad serotype 41 as two terminal exons in tandem. The F41T vector genome contains both short- and long-shafted fibers from Ad serotype 41. HEK-293 monolayer cultures were kept in Dulbecco modified Eagle medium (DMEM) plus 5% to 10% calf serum. FL83B murine hepatocyte (ATCC CLR- 2390) cultures were maintained in F12K plus 10% fetal bovine serum (FBS). P6 macrophages were kindly provided by A. Ding and kept in DMEM plus 10% FBS. In vitro transduction assays. Cell lines used in this study were seeded into 24-well plates and infected with 1,000 or 5,000 particles/cell in medium without serum for 30 min at 37 C. After infection, virus was aspirated and fresh medium was added back. Infected cells were harvested 24 h postinfection in TEN scrape buffer (40 mm Tris Hcl [ph 7.4], 1 mm EDTA, 0.15 M NaCl) and resuspended in 0.25 M Tris, ph 7.8. Lysates were subjected to three freeze-thaw cycles followed by a 10-min incubation at 65 C to inactivate cellular deacetylases. Chloramphenicol acetyltransferase (CAT) activity assays were performed as described previously (6). In vivo transduction assays. Six-week-old female B6129/J mice were obtained from Taconic or Jackson Laboratories and maintained in compliance with institutional protocols. Mice were injected retro-orbitally with virus particles or PBS vehicle alone in a total volume of 100 l. At indicated time points, animals were sacrificed and organs were harvested, weighed, and resuspended in 2 volumes PBS by weight. Tissue lysates were prepared by homogenizing organs and centrifuging them for 30 min at 3,000 g, followed by a 10-minute incubation at 65 C. Total tissue CAT activity was assayed as described above. DNA isolation and Southern analysis. Livers from Ad- or mock-infected animals were harvested, and a portion was used for DNA isolation. Tissue slices were pulverized in Eppendorf tubes and incubated in lysis buffer (10 mm Tris [ph 8.0], 400 mm NaCl, 2 mm EDTA, 0.5% sodium dodecyl sulfate [SDS], 0.4 mg/ml proteinase K) overnight at 55 C. Samples were treated with 2 l RNase A (10 mg/ml) for 30 min at 37 C. DNA was purified by two rounds of phenol- CHCl 3 extraction and a CHCl 3 -only extraction, followed by ethanol precipitation. For Southern analysis, 10 g DNA was digested with EcoRI and electrophoresed on a 1% agarose gel. Samples were transferred to a nylon membrane, and blots were probed with either EcoRI-digested Ad5 vector DNA or -actin. DNA levels were quantified by PhosphorImager analysis. RNA isolation and RPA. Bone marrow-derived macrophages (BMMOs) and liver sections from Ad- or mock-infected animals were harvested for RNA isolation with Trizol reagent (Invitrogen) according to the manufacturer s instructions. Five (BMMO) or 10 (liver) g of total RNA was hybridized to 32 P-labeled probes generated from either the mck3b (cytokine) or mck5c (chemokine) multiprobe template sets (Pharmingen). A commercially available RNase protection assay (RPA) kit (Pharmingen) was used to RNase treat samples and recover protected fragments. Resolution of protected fragments was carried out by electrophoresis on 10% polyacrylamide sequencing gels. Gels were dried and exposed to a PhosphorImager screen, and mrna species were quantified by PhosphorImager analysis. Anti-Ad neutralizing antibody blocking assay. Neutralizing antibody titers were determined by a functional in vitro blocking assay in HeLa cells. Serum samples from mice infected with the various vectors were taken at day 28 and serially diluted in DMEM. Serum dilutions were incubated with particles of a standard Ad5CAT vector for 1hat37 C. The serum/virus mixture was then added to 10 5 HeLa cells for 30 min at 37 C. Cells were washed with DMEM, and fresh medium was added back. CAT activity in cell extracts was scored 24 h later as described above. Anti-CAT antibody ELISA. To detect serum levels of antitransgene antibody, Maxisorp enzyme-linked immunosorbent assay (ELISA) plates (Nalge Nunc International) were coated with CAT (Sigma) in 50 mm sodium carbonate buffer, ph 9.6, for at least 16 h at 4 C. The CAT solution was removed, and 1% casein (Sigma) in PBS was added as a blocking buffer for 1hatroom temper-

3 VOL. 79, 2005 ADENOVIRUS-MEDIATED IMMUNE ACTIVATION FIG. 1. Fiber chimeric adenovirus vectors. (A) Graphical representation of the Ad5-based vectors used in this study. Ad5 is a standard E1/E3-deleted vector with wild-type fiber that binds CAR. F7 contains the full-length fiber from Ad7 in place of Ad5 fiber and binds a receptor other than CAR. F7F41S expresses both the fiber from Ad7 and the short fiber from Ad41, with the nonbinding fiber 41S dominating the capsid fiber content. F41T expresses both long (CAR binding) and short fibers from Ad41. (B and C) Protein content of purified virions. Virus particles (10 10 ) were resolved by SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and visualized by Western blotting with an antihexon antibody (B) or antifiber antibody (C). ature. Plates were washed three times in blocking buffer plus 0.05% Tween 20. Serum samples from 28-day-infected mice were serially diluted in blocking buffer and added to ELISA plates for 1.5 h at room temperature. Plates were washed three times as described above. A secondary horseradish peroxidase-conjugated anti-mouse antibody (Amersham) was diluted in blocking buffer plus 0.05% Tween 20 and added to plates for 1.5 h at room temperature. Plates were then washed four times as described above and incubated with the tetramethylbenzidine peroxidase substrate (Sigma). Reactions were stopped with1nh 2 SO 4, and plates were read at 450 nm on a spectrophotometer. BMMOs and bone marrow dendritic cell (BMDC) isolation and infection. Bone marrow macrophages were generated by culturing bone marrow cells in DMEM plus 20% FBS and 30% supernatant derived from L929 confluent cells, replacing two-thirds of the culture volume with fresh granulocyte-macrophage colony-stimulating factor (M-CSF)-containing medium every third day. Cells were used after 7 to 9 days, and all stained positive for CD11b but were negative for CD11c and B220. BMDCs were obtained by culturing bone marrow cells in DMEM plus 10% FBS in the presence of 15% supernatant derived from J558L cells as a source of GM-CSF, replacing two-thirds of the culture volume with fresh GM-CSF-containing medium every second to third day. Cells were used after 5 days and contained 60 to 90% CD11c cells. Cultures of BMMOs and BMDCs were infected with the indicated virus at 5,000 particles/cell. For transduction experiments, cells were harvested 24 h postinfection for CAT assays. For maturation phenotype, cells were harvested 48 h postinfection and stained on ice with phycoerythrin-conjugated anti-cd86 mouse antibody (Becton Dickinson) for 30 min in PBS containing 1% bovine serum albumin. Cells were fixed in 1% formalin and analyzed on an EPICS XL flow cytometer (Beckman Coulter). RESULTS Macrophage and hepatocyte transduction in vitro. Four fiber variants of Ad5 were selected to characterize the influence of fiber on transduction and immune activation. These viruses, Ad5, F7, F7F41S, and F41T, differ only in the nature of the fiber homotrimer(s) present in the viral capsid (Fig. 1A). The parental Ad5 virus is an E1/E3-deleted vector expressing wildtype fiber 5 with the cytomegalovirus immediate-early promoter driving expression of CAT as a reporter gene. The fiber present in this vector contains CAR binding domains as well as the putative HSG binding domain (KKTK) identified as being important for CAR-independent transduction. The F7 virus contains the full-length fiber sequence from the Ad7 subgroup B virus in place of fiber 5 (6). Subgroup B fibers do not bind CAR. The tandem fiber vectors express two distinct fiber proteins, either fiber 41S and fiber 41L (F41T) or fiber 7 and fiber 41S (F7F41S). F41L is a CAR binding fiber but does not contain the KKTK domain present in Ad5 fiber. Fiber 41S has no known binding function. Viruses were grown on a large scale in 293 cells, followed by two rounds of CsCl banding purification and dialysis to remove salts. Viral particle numbers were quantified by optical density at 260 nm (10 12 particles/unit of optical density at 260 nm). To confirm that each vector was quantitatively matched, particles of each vector were separated by SDS-polyacrylamide gel electrophoresis and analyzed by Western blotting with antihexon antibody (Fig. 1B). The blot was then probed with antifiber antibody (4D2 from Neomarkers) to demonstrate the fiber content of each of the vectors (Fig. 1C). The lack of fiber 7 in F7F41S is due to the preferred expression and incorpora-

4 11630 SCHOGGINS ET AL. J. VIROL. FIG. 2. Diminished in vitro transduction of fiber-modified vectors. Approximately murine FL83B hepatocytes (A) or P6 macrophages (B and C) were infected with each vector at 1,000 particles/cell (A and B) or 5,000 particles/cell (C) for 30 min. At 24 h postinfection, cell lysates were harvested for CAT activity. Data are representative of the average CAT activity standard errors of the means from at least two experiments performed in triplicate. tion of fiber 41S into virions (20). Based on this assay, the fiber content of F7F41S is essentially F41S. To determine transduction functions, a murine hepatocyte cell line (FL83B) and a murine macrophage cell line (P6) were infected with the indicated virus at 10 3 Ad particles/cell. Following a 30-minute incubation, cells were washed twice with fresh medium to remove free virus. Cells were incubated for 24 h and harvested for reporter gene assay. The Ad5 and F41T vectors were highly effective at delivering a transcriptionally active reporter gene (Fig. 2A) into FL83B murine hepatocyte cells. In comparison, transduction through CAR-independent fiber (F7) was decreased 100-fold compared to CAR-targeting viral vector. This contrasts with the efficient transduction mediated by F7 vectors in human cell lines (HeLa, HepG2, and A549) (20; data not shown). The low level of transduction by F7-containing viruses in FL83B hepatocytes is consistent with studies demonstrating low levels of subgroup B virus receptor(s) expression in murine cells (5). CAT gene transduction from F7F41S virus infection was over 200-fold lower than that from Ad5 and 500-fold less than that from F41T. The lack of transduction by F7F41S virus supports previous observations (20) that fiber 41S does not contribute to efficient cell binding and virus uptake. In contrast to transduction efficiency in the FL83B hepatocyte cell line, transduction of the P6 macrophage cells by the Ad5 vector was found to be very low, approximately 2 logs below transduction in FL83B cells when identical experimental conditions are used (compare Fig. 2A and B). The F7 virus was also unable to transduce the macrophage cell line, arguing that these cells also lack a suitable subgroup B receptor. Each of the tandem fiber vectors had similar and slightly higher transduction efficiencies in macrophage P6 cells. Similar results were found in the RAW264.7 murine macrophage cell line (data not shown). These results indicate that murine macrophage transduction is independent of CAR or subgroup B receptor uptake mechanisms. Because established cell lines do not always reflect the complete phenotype of a primary cell type, we chose to compare the transduction of the P6 macrophage cell line with cultured primary BMMOs isolated from B6129/J mice. Cells (P6 or BMMOs) were infected with a slightly higher dose of virus (5,000 particles/cell), and CAT transduction assays were performed (Fig. 2C). CAT expression in P6 cells was increased approximately fivefold compared to infections with 1,000 particles/cell, reflecting a dose response to each of the fiber chimeric constructs. At 5,000 particles/cell, transduction of the BMMOs was significantly higher than transduction of established macrophage cell lines. At this dose of vector, there was no apparent difference in transduction between the fiber chimeras. This result reveals an indifference of macrophages to the fiber type present in the Ad5 capsid. Macrophages contribute to the early inflammatory response to pathogens and have been implicated in the antiviral response to Ad vectors. To determine if the fiber chimeras differentially activate macrophages, we assessed the maturation of BMMOs by upregulation of costimulatory molecules (such as CD86, CD40, or major histocompatibility complex class II). At 24 h following virus infection, BMMOs were stained with anti-cd86 antibody and subjected to flow cytometry. Essentially 100% of CD11b-positive BMMOs underwent activation as revealed by upregulation of CD86 regardless of the fiber configuration (Fig. 3A). To assess an early activation response of BMMOs to the chimeric viruses, BMMOs were infected as previously described and harvested 5 h postinfection for total RNA. RNA from each infection was used in an RNase protection assay to quantify induction of cytokine and chemokine mrna. Using a cytokine multiprobe template set under the experimental conditions described, each fiber chimera was found to induce expression of tumor necrosis factor alpha (TNF- ) mrna (Fig. 3B). Similar expression patterns were seen for gamma interferon (IFN- )-inducible protein 10, macrophage inflammatory protein 1, and T-cell activation gene 3 using a chemokine multiprobe template set (Fig. 3C). At the level of transduction and activation, the data clearly indicate that each of the chimeric constructs is able to transduce and effectively stimulate primary macrophage cells. CAR-mediated transduction and viral DNA localization. CAR-dependent infection is a primary mechanism responsible for high-level Ad vector gene transduction in murine hepatocyte cell lines, but transduction in macrophage cells occurs in a fiber/car-independent manner. We next asked how the fiber modifications in our vectors influence sequestration and transduction at early times after systemic administration. B6129/J mice were infected with virus particles by intravenous injection. At 5 and 24 h, animals were sacrificed. Liver and

5 VOL. 79, 2005 ADENOVIRUS-MEDIATED IMMUNE ACTIVATION FIG. 3. Activation of BMMOs by chimeric vectors. BMMOs ( ) were infected with 5,000 particles/cell or mock infected and harvested at 48 h for staining with anti-cd86 antibody (A) or at 5 h postinfection for RNA isolation (B and C). Total RNA was analyzed for induction of cytokine (B) or chemokine (C) mrnas by RNase protection assay as described in Materials and Methods. Transcript levels were quantitated by PhosphorImager analysis and normalized to ribosomal protein L32 mrna levels. Data are means of triplicates standard errors of the means. IP-10, gamma interferon-inducible protein 10; MIP-1, macrophage inflammatory protein; TCA-3, T-cell activation gene 3; LPS, lipopolysaccharide. FIG. 4. Diminished in vivo transduction and vector uptake of fibermodified vectors. Groups of three female B6129/J mice were injected with virus particles per mouse and killed 5hor24hpostinfection. (A) Liver samples were assayed for total liver CAT activity as described in Materials and Methods. Data are means standard errors of the means of two independent experiments, each performed in triplicate. (B) DNA was extracted from liver tissue and digested with EcoRI. Ten micrograms of digested DNA was separated on a 1% agarose gel and transferred to a nylon membrane, and blots were probed with either EcoRI-digested Ad5 vector DNA or -actin (not shown). (C) Hexon DNA levels from Southern blots were quantitated by PhosphorImager analysis and normalized to cellular -actin levels. The data are representative of two independent experiments standard errors of the means. spleen were harvested for reporter gene expression, total DNA, and total RNA. CAT expression at 5 h postinfection represents an efficient uptake and gene expression process. Under our experimental conditions, the CAR-targeted vectors were able to mediate strong levels of CAT expression by 5 h postinfection (Fig. 4A). The results obtained at 5 h are similar to the pattern seen in hepatocytes (Fig. 2A) where CARdependent transduction is prevalent, but a blending of hepatocyte and macrophage infections may better represent the overall hepatic expression pattern. At 24 h postinfection the magnitude of expression has increased with all vectors, without an overwhelming fiber-directed bias. Consistent with a detargeting phenotype, the F7 and F7F41S vectors yield 20- to 50-fold-less hepatic transgene expression than Ad5 fiber vectors. Assays characterizing CAT activity in kidney, lung, and intestine showed that activity was well below the low levels found in spleen and therefore the levels were viewed as background (data not shown). In contrast to transgene expression, a different pattern was found when characterizing the yield of total viral DNA localized to the liver. DNA was isolated from liver harvested 5 and 24 h postinfection with each of the viruses. The CAR binding viruses result in high levels of gene expression but diverge greatly with respect to total viral DNA localized to the liver (Fig. 4B and C). Ad5 vector DNA is present at the greatest level 5 h postinfection whereas F41T is present at the lowest level. Since both of these vectors transduce through CAR at similar efficiencies (Fig. 2A), the observed variation in local-

6 11632 SCHOGGINS ET AL. J. VIROL. ization is attributed to non-car-binding attributes of fiber 5 compared to fiber 41L or 41S of F41T. As previously mentioned, Ad5 fiber contains a putative HSG binding domain, which is absent in the 41L/S fibers. Although the F7 vector yields the lowest level of transduction, it was second to Ad5 with respect to viral DNA localized to the liver at 5 h postinfection, with F7F41S present at a slightly lower concentration. When total DNA isolated from splenic tissue was probed for viral DNA by Southern blotting, levels were minimal compared to liver for all samples (data not shown); therefore, detargeted vectors were not retargeted to spleen. These data indicate disassociation between viral DNA localization and transgene expression at the 5-hour time point. At 24 h postinfection, the majority of viral DNA present at 5 h is eliminated. DNA from the Ad5 infection is clearly above background levels (Fig. 4B and C). For Ad5-based vectors, the elimination of vector DNA present at 5 h and absent at 24 h has been attributed to vector clearance by Kupffer cells (31). For both CAR binding and non-car-binding vectors, the majority of viral DNA initially localized to the liver is not associated with gene transduction and has been eliminated by 24 h postinfection. Altered chemokine and cytokine profiles as a function of fiber modification. The fiber-modified viruses are distinguished from one another by the efficiency of gene expression as well as the magnitude of virus localized to the liver. We next asked if these differences in virus targeting would have an impact on immune activation by the host. To characterize the overall early inflammatory response to the fiber-modified vectors, we first characterized serum levels of TNF- and interleukin-6 (IL-6) at 5 and 24 h postinfection by ELISA. Under the experimental conditions described (10 10 viral particles/animal) levels of TNF- and IL-6 in serum did not increase over those found in mock-infected animals (data not shown). We then isolated RNA from portions of liver harvested at 5 and 24 h postinfection as described in the previous section. Samples (10 g) of RNA were used in an RNase protection assay using the mck3b cytokine template set (BD Biosciences) to determine if the fiber-modified vectors induce novel patterns of cytokine activation. Under our experimental conditions (infection of each animal with viral particles), Ad-mediated induction of cytokine mrna from total liver was very modest at 5 h postinfection (Fig. 5A) (and lower at 24 h [data not shown]). Using PhosphorImager analysis of protected liver RNA species (Fig. 5B), we found that TNF- transcripts were induced in animals infected with the Ad5 vector compared to liver isolated from animals infected with the fiber-modified viruses. We also found that mrnas for two other cytokines, IFN- and macrophage inducing factor, were induced compared to mock-infected animals. Based on the magnitude of induction, the upregulation of cytokine mrna is roughly consistent with viral DNA localization to the liver (compare Fig. 3C and 5B). Analysis of RNA harvested from animals after 24-hour virus exposure revealed baseline concentrations for all cytokine mrnas (data not shown). RNA generated from the infections harvested at 5 h was also used to determine Ad induction of chemokines using the mck5c chemokine template set. Results from this assay revealed a chemokine mrna induction profile that was fiber dependent and distinct from the cytokine mrna induction FIG. 5. Liver cytokine mrna levels decreased by fiber-modified vectors. Groups of three female B6129/J mice were injected with virus particles per mouse. At 5 h postinjection, total liver RNA was isolated and analyzed for cytokine mrna levels by RNase protection assay as described in Materials and Methods. Control lane corresponds to RPA products generated from manufacturer-supplied mck3b-positive control mrna (A). Transcript levels were quantitated by PhosphorImager analysis and normalized to ribosomal protein L32 mrna levels (B). Data are means of triplicates standard errors of the means. MIF, macrophage-inducing factor; GAPDH, glyceraldehyde- 3-phosphate dehydrogenase; TGF, transforming growth factor. pattern (Fig. 6A and B). The chemokine mrna expression pattern resembled the pattern of fiber-dependent gene transduction (compare Fig. 3A and 6B). IFN- -inducible protein 10 and T-cell activation gene 3 mrnas were highly induced by both CAR binding viruses, and macrophage inflammatory protein 1 was expressed at more moderate levels. After normalization, the non-car-binding viruses F7 and F7F41S were slightly above baseline levels of mock-infected animals but 10- to 20-fold less than the CAR-targeted vectors. These studies demonstrate that fiber-mediated detargeting of otherwise identical vectors has a demonstrable impact on the induction of both cytokines and chemokines associated with early stages of the anti-ad immune response. Clearance efficiency and humoral immunity unchanged by fiber modifications. Based on the observations that the fibermodified viruses were compromised in induction of intrahepatic inflammatory cytokine/chemokine mrna, we next asked if we could detect a significant difference in the adaptive immune response to virus infection. It is well established that cytotoxic T cells are largely responsible for clearance of Ad-

7 VOL. 79, 2005 ADENOVIRUS-MEDIATED IMMUNE ACTIVATION FIG. 6. Liver chemokine mrna levels decreased by fiber-modified vectors. Groups of three female B6129/J mice were injected with virus particles per mouse. At 5 h postinjection, total liver RNA was isolated and analyzed for chemokine mrna levels by RNase protection assay as described in Materials and Methods. Control lane corresponds to RPA products generated from manufacturer-supplied mck5c-positive control mrna (A). Transcript levels were quantitated by PhosphorImager analysis and normalized to ribosomal protein L32 mrna levels (B). Data are means of triplicates standard errors of the means. IP-10, gamma interferon-inducible protein 10; MIP-1, macrophage inflammatory protein; TCA-3, T-cell activation gene 3; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. infected cells following an in vivo infection in an immunocompetent host (33). Therefore, if fiber-modified viruses do not activate the cellular immune response as effectively as Ad5, we would predict increased persistence over time of CAT-expressing cells. Similarly if the modified vectors influence the humoral immune response to Ad, we would predict a diminished level of anti-ad antibody to be present in infected animals. To test these elements of the immune response to fiber-modified vectors, we established a 4-week time course experiment infecting B6129/J mice with particles of the indicated virus. Animals were sacrificed at the indicated time point, and liver, spleen, and serum were harvested. The profiles for transgene expression over the 4-week time course for the modified viruses were remarkable in their similarity to Ad5 vector (Fig. 7). In liver, peak expression for each construct occurred at 3 days postinfection (Fig. 7A). CAT expression began to decline at 6 days postinfection, and by 28 days CAT expression had returned to baseline levels in all animals. Similarly, the kinetics of CAT transgene expression FIG. 7. Similar transduction kinetics of Ad5-based fiber chimeric vectors in vivo. Groups of three to five female B6129/J mice were injected retro-orbitally with virus particles per mouse. Mice were killed 24 h, 3 days, 6 days, or 28 days postinfection, and total CAT activity was determined in liver (A) and spleen (B) as described in Materials and Methods. Data are means of three to five mice standard errors of the means. and clearance from spleen were essentially identical (Fig. 7B). The only distinguishing feature was the magnitude of transgene expression. At the level of vector clearance, the fibermodified vectors were eliminated as efficiently as the Ad5 vector. We next determined the level of anti-ad neutralizing antibody in serum isolated from animals 28 days postinfection by an antibody-blocking assay as described in Materials and Methods. Each of the fiber-modified viruses induced blocking antibody to Ad5 (Fig. 8A). However, the efficiency of blocking activity was lower in serum generated from infections with the fiber-modified vectors. Because these studies were blocking Ad5 infection and not the dosing vector, this slightly diminished response may reflect differences in antibody directed to serotype-specific fibers. To determine if the neutralizing antibody generated in response to the fiber-modified vectors was biologically significant, we used an in vivo readministration assay (7, 9). Animals were injected with particles of each virus, and on day 25 postinfection, when CAT expression is at baseline, each animal was injected with particles of Ad5CAT. Livers were har-

8 11634 SCHOGGINS ET AL. J. VIROL. FIG. 8. Induction of anti-ad neutralizing and antitransgene antibodies by fiber-modified vectors. (A) Anti-Ad neutralizing antibody titer assay. Serum levels of anti-ad neutralizing antibody were determined by a functional in vitro transduction blocking assay as described in Materials and Methods. Data are means of three mice per group standard errors of the means. (B) Efficacy of neutralizing antibodies in blocking Ad5 vector readministration. Groups of six mice were injected with virus particles per mouse or vehicle buffer. At 25 days postinjection, three mice in each group received a booster of Ad5CAT virus particles. Three days later (day 28), livers from all mice were harvested and assayed for CAT activity. Data are means standard errors of the means. (C) Anti-CAT ELISA. Serum samples from mice infected for 28 days were assayed for anti-cat antibody levels by ELISA. Data are means of serum samples from three mice assayed in triplicate. vested 3 days postinfection and assayed for CAT gene expression. Regardless of the vector used in the original administration, all animals were able to effectively block Ad5CAT gene transduction in our readministration protocol (Fig. 8B). The CAR detargeted vectors are significantly less effective in transducing cells in vivo, resulting in a diminished level of overall CAT gene product. To determine if the efficiency of transgene expression correlated with the serum levels of anti- CAT antibody, we quantified anti-cat antibody by ELISA (Fig. 8C). Serum levels of anti-cat antibody were lowest for Ad5, which expressed the highest level of CAT. The modified vectors generated similar or slightly higher levels of anti-cat antibody. In contrast to the different levels of liver and spleen CAT gene expression mediated by the fiber-modified viruses, anti-cat antibody was found to be essentially the same for each of the viruses examined. Transduction and maturation of bone marrow-derived dendritic cells by fiber-modified viruses. We have used two basic endpoint assays (clearance of infected cells and anti-ad humoral immunity) to demonstrate that the adaptive immune response to fiber-modified vectors is largely unaffected by the efficiency of gene transduction or the magnitude of the inflammatory response as characterized by the cytokine/chemokine RNA induction profile. These results would argue that recognition of these vectors by specialized antigen-presenting cells of the immune system (primarily macrophages and dendritic cells) is unaffected by fiber detargeting functions. We have already demonstrated that primary macrophages are responsive to Ad in a fiber-independent manner. Dendritic cells are considered the primary effector cells of the adaptive arm of the immune system and have been shown to respond to adenovirus infection (14, 17, 18, 29). The fiber-modified viruses were used to infect BMDCs ( particles/cell) as previously described. Levels of CAT expression in BMDCs were significantly below those previously identified in BMMOs, approximately 10- to 20-fold less under comparable conditions (compare Fig. 3C to 9A). All vectors were above background, and the F7 construct was again found to be the least effective at CAT transduction (Fig. 9A). We next determined if the fiber-modified viruses influenced BMDC maturation/activation. Immature BMDCs express low levels of cell surface markers including CD86. When exposed to a stimulating antigen (Ad5 virus), immature BMDCs undergo maturation characterized by upregulation of cell surface markers including CD86 (17). We found that exposure of BMDCs to Ad5, F41T, and F7F41S resulted in upregulation of CD86 compared to mockinfected BMDCs (Fig. 9B). Upregulation of CD86 following BMDC exposure to the F7 virus was no different from that with mock-infected DCs. The observation that F7 demonstrated diminished transduction and activation in DCs led us to test if increasing doses of F7 would lead to increasing transduction and activation of BMDCs. The BMDCs were incubated with increasing doses of F7 virus, and 24 h postinfection, a portion of each infection was harvested for measurement of CAT gene expression. A control infection of Ad5 at 5,000 particles indicated slightly higher levels of transduction than F7. With increasing doses of F7 virus, we found a corresponding increase in CAT gene expression (Fig. 9C). When the DCs were harvested at 48 h postinfection and characterized with respect to upregulation of the costimulatory molecules CD86 (Fig. 9D) and CD40 (Fig. 9E), we found that increasing concentrations of virus resulted in increased expression of the DC activation markers. Based on the data from this study, we found that fiber-modified viruses were able to induce upregulation of costimulatory molecules in bone marrow-derived dendritic cells. DISCUSSION The combination of uncontrolled vector delivery and virus uptake by cells of the immune system has presented major obstacles to the use of Ad vectors in gene therapy applications. In the current study we have used fiber-pseudotyped firstgeneration Ad vectors to characterize how fiber influences

9 VOL. 79, 2005 ADENOVIRUS-MEDIATED IMMUNE ACTIVATION FIG. 9. Ad transduction and induction of costimulatory molecules in dendritic cells is largely indifferent to fiber content. (A) DCs were infected with indicated vector at 5,000 particles/cell or mock infected with viral storage buffer. At 24 h postinfection a portion of cells were harvested and CAT gene expression was determined as previously described. (B) At 48 h postinfection, cells were harvested and incubated with anti-cd86 antibody. Flow cytometry was used to assess cell surface expression of CD86 as the percentage of total DC population expressing high CD86 levels. (C to E) Influence of increasing dose of F7 virus on gene transduction in DCs. DCs were incubated with the indicated dose of Ad vector for 24 h and harvested for quantitation of CAT gene expression as previously described, or after 48 h, cells were harvested and incubated with anti-cd86 antibody (D) or anti-cd40 antibody (E). Flow cytometry was used to determine increase in surface expression of costimulatory molecules as previously described. p, particles. gene transduction, vector localization, and immune stimulation following systemic administration in a murine model. Based on the observations made in this study and consistent with observations from other laboratories (13, 22, 26), Ad5 fiber contributes significantly to liver localization following a systemic administration of vector. When the Ad5 fiber is replaced with either fiber 7 or a combination of fiber 7 and fiber 41S, both vector localization to liver and vector-mediated gene transduction are greatly reduced. These constructs represent fiberdetargeted vectors. A major advantage of the fiber-detargeted vectors is a decrease in the magnitude of hepatic cytokine and chemokine mrna induction. Although both localization to the liver and vector-mediated gene transduction are greatly reduced with these constructs, they are not eliminated. Based on the results presented in this study, we consider residual localization to liver and low-level vector transduction with these constructs to result from fiber-independent transduction. This background may be attributed to low-affinity binding through nonfiber capsid proteins, such as penton base or hexon. Background localization/transduction may also result from nonspecific phagocytic/macropinocytotic uptake of viral particles. CAR-mediated transduction following a systemic administration of virus is revealed during very early time points (5 h), where an assay of transgene expression depends on efficient virus binding and internalization. Efficient CAT transduction is found with the CAR binding vectors. This result is consistent with in vitro transduction assays in the FL83B hepatocyte cell line (compare Fig. 3A and 2A). Although similar levels of CAT expression are found with both CAR binding vectors at 5 h postinfection, there is five times more Ad5 viral DNA localized to the liver than F41T viral DNA. Two conclusions can be made from this result. Following vector administration, as virus is passing through the hepatic tissue, CAR-mediated binding facilitates hepatic transduction equally with both CAR binding vectors. This conclusion would indicate that both the Ad5 and F41T vectors are initially presented to the hepatic cells in a manner that allows each to target through CAR with equal efficiency. Consistent with this hypothesis, other studies have shown that, regardless of the type of fiber present on Ad, similar amounts of virus are present in the liver within the first 30 min following a systemic infection (22). The second conclusion is that Ad5 fiber, compared to fiber 41L, increases vector residence time within the liver. This conclusion is derived from the observation that Ad5 vector localization to liver is five times that of any of the other vectors at 5 h postinfection. Differences in CAR binding efficiency do not account for the differences in localization between Ad5 and F41T. It is worth noting that the two CAR binding fibers (F5 and F41L) are essentially identical in fiber shaft length. Therefore, we do not consider fiber length to directly account for Ad5 localization to liver. Increased residence time can be attributed to other features of Ad5 fiber, for example, the putative HSG binding domain KKTK present in Ad5 fiber and absent in each of our

10 11636 SCHOGGINS ET AL. J. VIROL. pseudotyped fiber constructs. This domain has been shown to facilitate Ad5 hepatic localization following a systemic administration in both murine and rat models (16, 26). At time points of peak gene expression (days 1, 3, and 6) (Fig. 7) levels of Ad5-mediated CAT expression are above those seen with fiber-modified vectors. Transduction associated with the fiber-modified vectors F7 and F7F41S is roughly 1 to 5% of Ad5, whereas F41T-mediated CAT expression is approximately 10% of that found with Ad5. The F41T transduction differential compared to the non-car-binding vectors was approximately 10:1. This represents the enhancement of CAR-mediated transduction over fiber-detargeted vectors (F7 and F7F41S). The difference between F41T and Ad5 would be consistent with CAR-independent binding functions of Ad5 fiber. Based on the data presented in this study, the transduction differential between Ad5 and the fiber-modified vectors is consistent with a model in which Ad5 fiber mediated increased hepatic residence time. Therefore, overall levels of transduction are influenced by both CAR binding and non-car-binding mechanisms. In addition to helping define the role of fiber in Ad vector localization and gene transduction, these studies also revealed how fiber can influence the innate response to virus infection. Coincident with increased liver localization, the Ad5 fiber vector facilitates induction of higher levels of intrahepatic TNF- mrna compared to the pseudotyped vectors. In our studies we have used a comparatively low dose of virus, particles/ animal. At this dose of input virus, the induction of inflammatory response is at the limit of sensitivity for many assays. Serum ELISAs of infected animals for TNF- and IL-6 at 5 and 24 h postinfection showed levels indistinguishable from background levels (data not shown). However, using the RPA we were able to detect TNF- mrna induction at 5 h postinfection. Induction of cytokines by Ad5 vectors is well documented (at higher doses) and contributes to the strong anti-ad inflammatory response (33). In a recent study, Shayakhmetov et al. (22) characterized chimeric constructs containing fibers with different shaft and/or knob compositions using particles/animal. At this dose, when characterizing induction of cytokine mrna (TNF- ), all viruses induced expression at levels that were slightly over background at 6 h postinfection. They also found that constructs that contained the Ad5 fiber shaft induced higher levels of TNF- than viruses expressing Ad35 shaft (Ad35 is a subgroup B virus) by an ELISA. Our studies also support a model where the presence of Ad5 fiber shaft stimulates higher levels of TNF- mrna. In addition, we demonstrate that a long-shafted fiber such as F41L does not stimulate TNF- in the same manner as the Ad5 fiber. Taken together these results argue that the Ad5 fiber shaft that contains the KKTK domain contributes to TNF- mrna induction. CAR binding viruses were also shown to induce higher levels of intrahepatic chemokine mrna compared to the fiber-detargeted vectors. Upregulation of chemokine mrna at 5 h postinfection was not a function of total vector DNA localized to the liver, since the F41T vector induced chemokines to a level equal to that induced by Ad5. Rather chemokine induction more closely parallels CAR-mediated transduction. Shayakhmetov et al. (22) found heightened induction of IL-6, MCP-1, and IFN- with a CAR binding Ad5 fiber shaft construct (Ad5/9L) at particles/animal compared to their other constructs. They did not characterize a CAR binding virus that lacked the Ad5 fiber shaft and concluded that the shaft length was a major factor in cytokine activation. Our observations are consistent with a role of Ad5 fiber shaft in cytokine activation, but we would also conclude that there exists a distinct role for the CAR binding domain in stimulating elements of the innate immune system. Further investigation will be required to determine if the basis of chemokine induction by the CAR binding vectors is due to gene expression or to efficient early transduction mediated by CAR-directed uptake. In the murine system, the two non-car-binding vectors, F7 and F7F41S, represent simple platforms for pursuing a genetic strategy to retarget Ad vectors and offer the benefit of diminished induction of inflammatory cytokines. The F7 and F7F41S vectors also represent base platforms that can be used to explore the interaction of Ad vectors with cells of the immune system. Based on the decrease in liver (and spleen) localization, the decrease in liver (and spleen) transduction, and the decrease in intrahepatic induction of inflammatory cytokines, we asked if these vectors would also demonstrate a diminished ability to stimulate the adaptive immune response. Characterization of the adaptive immune response was based on straightforward endpoint assays relevant to gene therapy applications: clearance efficiency of transduced cells, antiviral humoral immunity, and the development of a humoral immune response to the delivered transgene CAT. In all cases, regardless of the assay or virus being tested, the adaptive immune response was largely indifferent to fiber. The detargeted vectors that resulted in diminished intrahepatic induction of chemokine mrnas were as effective as the Ad5 fiber vector in stimulating the adaptive arm of the immune response. Fiber-detargeted viruses mediate low-level gene transduction both in vitro and in vivo. We have shown that vector activation of antigen-presenting cells (both bone marrow-derived macrophages and dendritic cells) occurs in a fiber-independent manner in vitro. Consistent with in vitro observations, the threshold for activation of the adaptive arm of the immune response has been achieved in these studies with each of the fiber-pseudotyped vectors. In a previous study (17), we found that the RGD motif of the penton base was necessary to optimally activate DCs following exposure to Ad. In order to further compromise the immune activation of the fiber-detargeted vectors, we anticipate that an additional benefit can be obtained by combining fiber detargeting with the penton RGD mutations. Combining these capsid modifications with strategies such as use of tissue-specific promoters for transgene expression, expression of less immunogenic transgene, and use of second- or third-generation Ad vector backbones can in theory provide an Ad vector that has significant and greatly improved stealth characteristics. Alternatively as we learn more about how Ad vectors are recognized by cells of the immune system, we will be in a position to design vaccine or oncolytic vectors that have a significant enhancement in potency with diminished unwanted bystander activity. ACKNOWLEDGMENTS This work was supported by NIH grants AI to E.F.-P. and KO1 HL to M.N. GenVec has licensing agreements with

Cdc42 Activation Assay Kit

Cdc42 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Cdc42 Activation Assay Kit Catalog Number: 80701 20 assays 1 Table of Content Product Description 3 Assay

More information

Mag4C-Ad Kit - Results

Mag4C-Ad Kit - Results Mag4C-Ad Kit - Results Mag4C-Ad Kit Magnetic capture for viral concentration & storage buffer for superior viral preservation OZ Biosciences is delighted to announce the launching of a new product Mag4C-Ad

More information

Quality Control Assays

Quality Control Assays QUALITY CONTROL An integral part of the Penn Vector Core is its robust quality control program which is carried out by a separate quality control group. Quality control assays have been developed and optimized

More information

ICH Considerations. Oncolytic Viruses September 17, 2009

ICH Considerations. Oncolytic Viruses September 17, 2009 INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations Oncolytic Viruses September 17, 2009 1. Introduction Oncolytic viruses

More information

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Strategies for Assessment of Immunotoxicology in Preclinical Drug Development Rebecca Brunette, PhD Scientist, Analytical Biology SNBL USA Preclinical Immunotoxicology The study of evaluating adverse effects

More information

ICH CONSIDERATIONS Oncolytic Viruses

ICH CONSIDERATIONS Oncolytic Viruses European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ICH CONSIDERATIONS Oncolytic Viruses 20 November 2008 EMEA/CHMP/GTWP/607698/2008

More information

Rab5 Activation Assay Kit

Rab5 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Rab5 Activation Assay Kit Catalog Number: 83701 20 assays 24 Whitewoods Lane 1 Table of Content Product

More information

Arf6 Activation Assay Kit

Arf6 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Arf6 Activation Assay Kit Catalog Number: 82401 20 assays NewEast Biosciences 1 Table of Content Product

More information

Adenovirus Titration Kit

Adenovirus Titration Kit Adenovirus Titration Kit Catalog # LF-RK0001(1 kit) Immunostaining method for Quantitative Detection of Adenovirus For research use only Not for diagnostic or therapeutic procedures AbFrontier Science

More information

Human TNF-alpha / TNFA / TNFSF2 ELISA Pair Set

Human TNF-alpha / TNFA / TNFSF2 ELISA Pair Set Human TNF-alpha / TNFA / TNFSF2 ELISA Pair Set Catalog Number : SEKA10602 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized

More information

1. Cross-linking and cell harvesting

1. Cross-linking and cell harvesting ChIP is a powerful tool that allows the specific matching of proteins or histone modifications to regions of the genome. Chromatin is isolated and antibodies to the antigen of interest are used to determine

More information

RheB Activation Assay Kit

RheB Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based RheB Activation Assay Kit Catalog Number: 81201 20 assays NewEast Biosciences 1 FAX: 610-945-2008 Table

More information

Supplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence

Supplementary Figure 1. Characterization of the POP2 transcriptional and post-transcriptional regulatory elements. (A) POP2 nucleotide sequence 1 5 6 7 8 9 10 11 1 1 1 Supplementary Figure 1. Characterization of the POP transcriptional and post-transcriptional regulatory elements. (A) POP nucleotide sequence depicting the consensus sequence for

More information

Efficient Method for Isolation of High Quality Concentrated Cellular RNA with Extremely Low Levels of Genomic DNA Contamination Application

Efficient Method for Isolation of High Quality Concentrated Cellular RNA with Extremely Low Levels of Genomic DNA Contamination Application Efficient Method for Isolation of High Quality Concentrated Cellular RNA with Extremely Low Levels of Genomic DNA Contamination Application Gene Expression Authors Ilgar Abbaszade, Claudia Robbins, John

More information

Adeno-X Rapid Titer Kit

Adeno-X Rapid Titer Kit User Manual Adeno-X Rapid Titer Kit User Manual United States/Canada 800.662.2566 Asia Pacific +1.650.919.7300 Europe +33.(0)1.3904.6880 Japan +81.(0)77.543.6116 Clontech Laboratories, Inc. A Takara Bio

More information

Supplementary Information: Materials and Methods. Immunoblot and immunoprecipitation. Cells were washed in phosphate buffered

Supplementary Information: Materials and Methods. Immunoblot and immunoprecipitation. Cells were washed in phosphate buffered Supplementary Information: Materials and Methods Immunoblot and immunoprecipitation. Cells were washed in phosphate buffered saline (PBS) and lysed in TNN lysis buffer (50mM Tris at ph 8.0, 120mM NaCl

More information

ReliaBLOT TM. IP/Western Blot Reagents Cat. No. WB120, rabbit

ReliaBLOT TM. IP/Western Blot Reagents Cat. No. WB120, rabbit ReliaBLOT TM Introduction: IP/Western Blot Reagents Cat. No. WB120, rabbit ReliaBLOT TM IP/Western Blot Reagents and Procedures (patent pending) provide an improved method for the detection of immunoprecipitated

More information

Gα 13 Activation Assay Kit

Gα 13 Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Gα 13 Activation Assay Kit Catalog Number: 80401 20 assays NewEast Biosciences 1 Table of Content Product

More information

RayBio Human NF-κB p65 Transcription Factor Activity Assay Kit

RayBio Human NF-κB p65 Transcription Factor Activity Assay Kit RayBio Human NF-κB p65 Transcription Factor Activity Assay Kit Catalog #: TFEH-p65 User Manual Mar 13, 2017 3607 Parkway Lane, Suite 200 Norcross, GA 30092 Tel: 1-888-494-8555 (Toll Free) or 770-729-2992,

More information

Mag4C-Lv Kit - Results

Mag4C-Lv Kit - Results Mag4C-Lv Kit - Results Mag4C-Lv Kit Magnetic capture for viral concentration & storage buffer for superior viral preservation OZ Biosciences is delighted to announce the launching of a new product Mag4C-Lv

More information

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008

ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 European Medicines Agency October 2009 EMEA/CHMP/ICH/607698/2008 ICH Considerations Oncolytic Viruses ONCOLYTIC VIRUSES (EMEA/CHMP/ICH/607698/2008) TRANSMISSION TO CHMP November 2008 TRANSMISSION TO INTERESTED

More information

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Contacts: Marty Simonetti martysimonetti@gmail.com Kirby Alton kirby.alton@abeomecorp.com Rick Shimkets

More information

RayBio Human IL-18 ELISA Kit

RayBio Human IL-18 ELISA Kit RayBio Human IL-18 ELISA Kit Catalog #: ELH-IL18 User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,

More information

Supporting Information

Supporting Information Supporting Information Tal et al. 10.1073/pnas.0807694106 SI Materials and Methods VSV Infection and Quantification. Infection was carried out by seeding 5 10 5 MEF cells per well in a 6-well plate and

More information

Rhesus CD16 / FCGR3 ELISA Pair Set

Rhesus CD16 / FCGR3 ELISA Pair Set Rhesus CD16 / FCGR3 ELISA Pair Set Catalog Number : SEK90013 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General

More information

EZ-10 SPIN COLUMN GENOMIC DNA MINIPREPS KIT HANDBOOK

EZ-10 SPIN COLUMN GENOMIC DNA MINIPREPS KIT HANDBOOK EZ-0 SPIN COLUMN GENOMIC DNA MINIPREPS KIT HANDBOOK (Bacteria, Plant, Animal, Blood) Version 8 Rev 05/0/03 EZ-0 Genomic DNA Kit Handbook Table of Contents Introduction Limitations of Use Features Applications

More information

Gα i Activation Assay Kit

Gα i Activation Assay Kit A helping hand for your research Product Manual Configuration-specific Monoclonal Antibody Based Gα i Activation Assay Kit Catalog Number 80301 20 assays NewEast Biosciences, Inc 1 Table of Content Product

More information

Human Transferrin / TF ELISA Pair Set

Human Transferrin / TF ELISA Pair Set Human Transferrin / TF ELISA Pair Set Catalog Number : SEK11019 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the

More information

Human CEACAM6 ELISA Pair Set

Human CEACAM6 ELISA Pair Set Human CEACAM6 ELISA Pair Set ( CD66c ) Catalog Number : SEK10823 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the

More information

AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ

AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ AN EXAMINATION OF THE EFFECTS OF SIMVASTATIN ON INNATE IMMUNE RESPONSES TO S. AUREUS A RESEARCH PAPER BY TRACI STANKIEWICZ SUBMITTED TO THE GRADUATE SCHOOL IN PARTIAL FULFILLMENT OF THE REQUIRMENTS SET

More information

Adeno-X Rapid Titer Kit User Manual

Adeno-X Rapid Titer Kit User Manual Adeno-X Rapid Titer Kit User Manual Cat. No. 631028 PT3651-1 (PR5X1070) Published 30 September 2005 Table of Contents I. Introduction & Protocol Overview 3 II. List of Components 5 III. Additional Materials

More information

Supplementary Figure 1: Sequence alignment of partial stem region of flaviviruses

Supplementary Figure 1: Sequence alignment of partial stem region of flaviviruses Supplementary Figure 1: Sequence alignment of partial stem region of flaviviruses E prtoeins. Polyprotein sequences of viruses were downloaded from GenBank and aligned by CLC Sequence Viewer software.

More information

VDL602.2 RAPID ASSAY FOR DETERMINING ADENOVIRAL VECTOR TITER

VDL602.2 RAPID ASSAY FOR DETERMINING ADENOVIRAL VECTOR TITER 1. Purpose 1.1. The purpose of this protocol is to determine the number of infectious adenoviral particles. 1.2. The starting material is purified adenoviral vectors. 1.3. This protocol is based upon the

More information

Expectations for Biodistribution (BD) Assessments for Gene Therapy (GT) Products

Expectations for Biodistribution (BD) Assessments for Gene Therapy (GT) Products Expectations for Biodistribution (BD) Assessments for Gene Therapy (GT) Products Approved by the IPRP Management Committee on 3 June 2018 12 April 2018 Table of Contents 1. Position Statement... 3 2. Executive

More information

EPIGENTEK. EpiQuik Tissue Chromatin Immunoprecipitation Kit. Base Catalog # P-2003 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE

EPIGENTEK. EpiQuik Tissue Chromatin Immunoprecipitation Kit. Base Catalog # P-2003 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE EpiQuik Tissue Chromatin Immunoprecipitation Kit Base Catalog # P-2003 PLEASE READ THIS ENTIRE USER GUIDE BEFORE USE The EpiQuik Tissue Chromatin Immunoprecipitation Kit is suitable for combining the specificity

More information

Human IL10RB ELISA Pair Set ( CRFB4 )

Human IL10RB ELISA Pair Set ( CRFB4 ) Human IL10RB ELISA Pair Set ( CRFB4 ) Catalog Number : SEK10945 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the

More information

SI Appendix. Tumor-specific CD8 + Tc9 cells are superior effector than Tc1 cells for. adoptive immunotherapy of cancers

SI Appendix. Tumor-specific CD8 + Tc9 cells are superior effector than Tc1 cells for. adoptive immunotherapy of cancers SI Appendix Tumor-specific CD8 + Tc9 cells are superior effector than Tc1 cells for adoptive immunotherapy of cancers Yong Lu, Bangxing Hong, Haiyan Li, Yuhuan Zheng, Mingjun Zhang, Siqing Wang, Jianfei

More information

Human IFN-γ. Pre-Coated ELISA Kit

Human IFN-γ. Pre-Coated ELISA Kit Human IFN-γ (Interferon Gamma) Pre-Coated ELISA Kit Catalog No: 90-2067 1 96 well Format (96 tests) Detection Range: 15.6 1000 pg/ml Sensitivity: < 9.4 pg/ml This immunoassay kit allows for the in vitro

More information

IMMUNOPRECIPITATION (IP)

IMMUNOPRECIPITATION (IP) 1 IMMUNOPRECIPITATION (IP) Overview and Technical Tips 2 CONTENTS 3 7 8 9 12 13 17 18 19 20 Introduction Factors Influencing IP General Protocol Modifications Of IP Protocols Troubleshooting Contact Us

More information

RNA oligonucleotides and 2 -O-methylated oligonucleotides were synthesized by. 5 AGACACAAACACCAUUGUCACACUCCACAGC; Rand-2 OMe,

RNA oligonucleotides and 2 -O-methylated oligonucleotides were synthesized by. 5 AGACACAAACACCAUUGUCACACUCCACAGC; Rand-2 OMe, Materials and methods Oligonucleotides and DNA constructs RNA oligonucleotides and 2 -O-methylated oligonucleotides were synthesized by Dharmacon Inc. (Lafayette, CO). The sequences were: 122-2 OMe, 5

More information

TITLE: Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer. CONTRACTING ORGANIZATION: Louisiana State University Shreveport, Louisiana 71130

TITLE: Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer. CONTRACTING ORGANIZATION: Louisiana State University Shreveport, Louisiana 71130 AD AWARD NUMBER: W81XWH-05-1-0055 TITLE: Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer PRINCIPAL INVESTIGATOR: James M. Mathis, Ph.D. CONTRACTING ORGANIZATION: Louisiana State University

More information

MicroRNAs Modulate Hematopoietic Lineage Differentiation

MicroRNAs Modulate Hematopoietic Lineage Differentiation Chen et al., page 1 MicroRNAs Modulate Hematopoietic Lineage Differentiation Chang-Zheng Chen, Ling Li, Harvey F. Lodish, David. Bartel Supplemental Online Material Methods Cell isolation Murine bone marrow

More information

Human CD21 ELISA Pair Set

Human CD21 ELISA Pair Set Human CD21 ELISA Pair Set Catalog Number : SEKA10811 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General ELISA

More information

Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot)

Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Blotting Techniques (Southern blot, Northern blot, Western blot, and Eastern blot) Masheal Aljumaah SEP 2018 Learning Objectives: What is blotting? Blotting Techniques Types. Applications for each technique.

More information

His-Spin Protein Miniprep

His-Spin Protein Miniprep INSTRUCTIONS His-Spin Protein Miniprep Catalog No. P2001 (10 purifications) and P2002 (50 purifications). Highlights Fast 5 minute protocol to purify His-tagged proteins from cell-free extracts Screen

More information

The Molecular Virology Support Core: Adenoviral Vectors and Beyond

The Molecular Virology Support Core: Adenoviral Vectors and Beyond The : Adenoviral Vectors and Beyond Christoph A. Kahl, Ph.D. Viral Vector Workshop, May 5th, 2011 Outline 1) Overview of the MVSC 2) Adenoviral Vectors 3) Expertise and Services Overview What does the

More information

Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310

Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310 Data Sheet HVEM/NF-κB Reporter Jurkat Recombinant Cell Line Catalog # 79310 Product Description Recombinant clonal stable Jurkat T cell line expressing firefly luciferase gene under the control of 4 copies

More information

Tumor tissues or cells were homogenized and proteins were extracted using

Tumor tissues or cells were homogenized and proteins were extracted using SUPPLEMENTAL MATERIALS AND METHODS Western Blotting Tumor tissues or cells were homogenized and proteins were extracted using T-PER tissue protein extraction buffer. Protein concentrations were determined

More information

1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?

1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation? 1 Name MCB 150 Midterm Eam #1 (100 points total) Please write your full name on each page of the eam!! The eam consists of 17 questions (6 pages). Each has a different point count as indicated. Please

More information

Human C-Reactive Protein / CRP ELISA Pair Set

Human C-Reactive Protein / CRP ELISA Pair Set Human C-Reactive Protein / CRP ELISA Pair Set Catalog Number : SEK11250 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized

More information

IgG TrueBlot Protocol for Mouse, Rabbit or Goatderived Antibodies - For Research Use Only

IgG TrueBlot Protocol for Mouse, Rabbit or Goatderived Antibodies - For Research Use Only IgG TrueBlot Protocol for Mouse, Rabbit or Goatderived Antibodies - For Research Use Only Introduction The IgG TrueBlot for mouse, rabbit, or goat-derived antibodies represents unique series of respective

More information

Fig. S1 TGF RI inhibitor SB effectively blocks phosphorylation of Smad2 induced by TGF. FET cells were treated with TGF in the presence of

Fig. S1 TGF RI inhibitor SB effectively blocks phosphorylation of Smad2 induced by TGF. FET cells were treated with TGF in the presence of Fig. S1 TGF RI inhibitor SB525334 effectively blocks phosphorylation of Smad2 induced by TGF. FET cells were treated with TGF in the presence of different concentrations of SB525334. Cells were lysed and

More information

QuickTiter Adenovirus Titer ELISA Kit

QuickTiter Adenovirus Titer ELISA Kit Product Manual QuickTiter Adenovirus Titer ELISA Kit Catalog Number VPK-110 2 x 96 assays FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Recombinant adenoviruses have tremendous

More information

RayBio Human IL-18 BPa ELISA Kit

RayBio Human IL-18 BPa ELISA Kit RayBio Human IL-18 BPa ELISA Kit Catalog #: ELH-IL18BPA User Manual Last revised April 15, 2016 Caution: Extraordinarily useful information enclosed ISO 13485 Certified 3607 Parkway Lane, Suite 100 Norcross,

More information

TaKaRa MiniBEST Viral RNA/DNA Extraction Kit Ver.5.0

TaKaRa MiniBEST Viral RNA/DNA Extraction Kit Ver.5.0 Cat. # 9766 For Research Use TaKaRa MiniBEST Viral RNA/DNA Extraction Kit Ver.5.0 Product Manual Table of Contents I. Description... 3 II. Components... 3 III. Storage and shipping... 3 IV. Preparation

More information

DNA isolation from tissue DNA isolation from eukaryotic cells (max. 5 x 106 cells) DNA isolation from paraffin embedded tissue

DNA isolation from tissue DNA isolation from eukaryotic cells (max. 5 x 106 cells) DNA isolation from paraffin embedded tissue INDEX KIT COMPONENTS 3 STORAGE AND STABILITY 3 BINDING CAPACITY 3 INTRODUCTION 3 IMPORTANT NOTES 4 EUROGOLD TISSUE DNA MINI KIT PROTOCOLS 5 A. DNA isolation from tissue 5 B. DNA isolation from eukaryotic

More information

ELISA antibody pair Technical Data Sheet

ELISA antibody pair Technical Data Sheet ELISA antibody pair Technical Data Sheet 10-plate and 20-plate format For research use only. Not for use in diagnostic or therapeutic procedures. This Technical Data Sheet applies for the following U-CyTech

More information

Mouse IFNAR1 ELISA Pair Set

Mouse IFNAR1 ELISA Pair Set Mouse IFNAR1 ELISA Pair Set Catalog Number : SEK50469 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General ELISA

More information

Site directed mutagenesis, Insertional and Deletion Mutagenesis. Mitesh Shrestha

Site directed mutagenesis, Insertional and Deletion Mutagenesis. Mitesh Shrestha Site directed mutagenesis, Insertional and Deletion Mutagenesis Mitesh Shrestha Mutagenesis Mutagenesis (the creation or formation of a mutation) can be used as a powerful genetic tool. By inducing mutations

More information

This Document Contains:

This Document Contains: This Document Contains: 1. In-Cell Western Protocol II. Cell Seeding and Stimulation Supplemental Protocol III. Complete Assay Example: Detailing the Seeding, Stimulation and Detection of the A431 Cellular

More information

Applications Reported This ELISA set is for the quantitative detection of human GM-CSF in serum, plasma, and tissue culture supernatant samples.

Applications Reported This ELISA set is for the quantitative detection of human GM-CSF in serum, plasma, and tissue culture supernatant samples. Page 1 of 2 Human GM-CSF Uncoated ELISA Catalog Number: 88-8337 Also known as: Granulocyte Macrophage Colony-Stimulating Factor, CSF2 RUO: For Research Use Only. Not for use in diagnostic procedures. Product

More information

Rat IGF-1 ELISA Kit (rigf-1-elisa)

Rat IGF-1 ELISA Kit (rigf-1-elisa) Rat IGF-1 ELISA Kit (rigf-1-elisa) Cat. No. EK0377 96 Tests in 8 x 12 divisible strips Background Insulin-like growth factor 1 (IGF-1), also known as somatomedin C, is a polypeptide protein hormone similar

More information

Nature Biotechnology: doi: /nbt.4086

Nature Biotechnology: doi: /nbt.4086 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3 p815 p815-hcd2 Ag (-) anti-cd3

More information

Human BMP-2 ELISA Pair Set

Human BMP-2 ELISA Pair Set Human BMP-2 ELISA Pair Set Catalog Number : SEK10426 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General ELISA

More information

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003 Lecture 17: Drug targeting Last time: Today: Intracellular drug delivery Drug targeting Reading: T.J. Wickham, Ligand-directed targeting of genes to the site of disease, Nat. Med. 9(1) 135-139 (2003) Drug

More information

RetroNectin Dish (RetroNectin Pre-coated Dish, 35 mmφ)

RetroNectin Dish (RetroNectin Pre-coated Dish, 35 mmφ) Cat. # T110A For Research Use RetroNectin Dish Product Manual Table of Contents I. Description... 3 II. Components... 3 III. Storage... 3 IV. Materials Required but not Provided... 5 V. Gene Transduction...

More information

A guide to selecting control, diluent and blocking reagents

A guide to selecting control, diluent and blocking reagents Specializing in Secondary Antibodies and Conjugates A guide to selecting control, diluent and blocking reagents Optimize your experimental protocols with Jackson ImmunoResearch Secondary antibodies and

More information

A guide to selecting control, diluent and blocking reagents

A guide to selecting control, diluent and blocking reagents Specializing in Secondary Antibodies and Conjugates A guide to selecting control, diluent and blocking reagents Optimize your experimental protocols with Jackson ImmunoResearch Secondary antibodies and

More information

Ribonucleic acid (RNA)

Ribonucleic acid (RNA) Ribonucleic acid (RNA) Ribonucleic acid (RNA) is more often found in nature as a singlestrand folded onto itself. Cellular organisms use messenger RNA (mrna) to convey genetic information (using the nitrogenous

More information

Selected Techniques Part I

Selected Techniques Part I 1 Selected Techniques Part I Gel Electrophoresis Can be both qualitative and quantitative Qualitative About what size is the fragment? How many fragments are present? Is there in insert or not? Quantitative

More information

SuperTCRExpress TM Human TCR Vβ Repertoire CDR3 Diversity Determination (Spectratyping) and Quantitative Analysis Kit

SuperTCRExpress TM Human TCR Vβ Repertoire CDR3 Diversity Determination (Spectratyping) and Quantitative Analysis Kit SuperTCRExpress TM Human TCR Vβ Repertoire CDR3 Diversity Determination (Spectratyping) and Quantitative Analysis Kit Cat. No. H0521 Size: 2 sets (22 Vβ families/each, with enzymes) H0522 Size: 4 sets

More information

For quantitative detection of mouse IGF-1 in serum, body fluids, tissue lysates or cell culture supernatants.

For quantitative detection of mouse IGF-1 in serum, body fluids, tissue lysates or cell culture supernatants. Mouse IGF-1 ELISA Kit (migf-1-elisa) Cat. No. EK0378 96 Tests in 8 x 12 divisible strips Background Insulin-like growth factor 1 (IGF-1), also known as somatomedin C, is a polypeptide protein hormone similar

More information

Rat TNF-alpha ELISA Kit

Rat TNF-alpha ELISA Kit Rat TNF-alpha ELISA Kit 2 3 Contents Introduction 3 Reagents 3 Storage 4 Additional Materials Required 4 Reagent Preparation 5 Assay Procedure 6 Assay Procedure Summary 7 Calculation of Results 8 Specificity

More information

ab Ran Activation Assay Kit

ab Ran Activation Assay Kit ab173247 Ran Activation Assay Kit Instructions for Use For the simple and fast measurement of Ran activation. This product is for research use only and is not intended for diagnostic use. Version 1 Last

More information

Human VEGFR2/KDR ELISA Kit (hvegfr-elisa)

Human VEGFR2/KDR ELISA Kit (hvegfr-elisa) Human VEGFR2/KDR ELISA Kit (hvegfr-elisa) Cat. No. EK0544 96 Tests in 8 x 12 divisible strips Background Vascular endothelial growth factor receptor 2 (VEGFR-2), also known as kinase insert domain receptor

More information

Purification of Concentrated, High-Quality RNA from Cells and Tissues

Purification of Concentrated, High-Quality RNA from Cells and Tissues Purification of Concentrated, High-Quality RNA from Cells and Tissues ReliaPrep RNA Cell and Tissue Miniprep Systems Don Smith, Promega Corporation Products Featured: ReliaPrep RNA Cell Miniprep System

More information

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289

Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289 Data Sheet CD137/NF-κB Reporter - HEK293 Recombinant Cell Line Catalog # 79289 Background Human CD137 (4-1BB; TNFRS9) is an inducible co-stimulatory molecule that activates T cells. CD137:CD137L-mediated

More information

Human CALML5 ELISA Pair Set

Human CALML5 ELISA Pair Set Human CALML5 ELISA Pair Set Catalog Number : SEK11783 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General ELISA

More information

Supplementary Methods

Supplementary Methods Supplementary Methods Reverse transcribed Quantitative PCR. Total RNA was isolated from bone marrow derived macrophages using RNeasy Mini Kit (Qiagen), DNase-treated (Promega RQ1), and reverse transcribed

More information

Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors

Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Contact Us: www.pall.com/contact Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Dynamic High Capacity Mustang Q Membrane Units

More information

Pre-made expression Adenovirus product manual

Pre-made expression Adenovirus product manual Pre-made expression Adenovirus product manual Catalog# Product Name Amounts AVP001 RFP adenovirus AVP002 AVP004 AVP005 AVP011 AVP012 AVP017 AVP010 AVP013 AVP014 AVP015 AVP016 AVP-Null AVP001-PBS AVP002-PBS

More information

NAME TA SEC Problem Set 5 FRIDAY October 29, 2004

NAME TA SEC Problem Set 5 FRIDAY October 29, 2004 MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel NAME TA SEC 7.012 Problem Set 5 FRIDAY October 29,

More information

Table of Contents. I. Description...2. II. Components and Storage...2. III. Reagents and Instruments Required but not Supplied in the Kit...

Table of Contents. I. Description...2. II. Components and Storage...2. III. Reagents and Instruments Required but not Supplied in the Kit... Table of Contents I. Description...2 II. Components and Storage...2 III. Reagents and Instruments Required but not Supplied in the Kit...4 IV. Gene Transduction...4 V. Transduction Protocol...5 A. RetroNectin

More information

High throughput screening: Huh-7 cells were seeded into 96-well plate (2000

High throughput screening: Huh-7 cells were seeded into 96-well plate (2000 1 SUPPLEMENTARY INFORMATION METHODS 6 7 8 9 1 11 1 1 1 1 16 17 18 19 High throughput screening: Huh-7 cells were seeded into 96-well plate ( cells/well) and infected with MOI of DENV-. One hour post-infection

More information

SUPPLEMENTAL INFROMATION

SUPPLEMENTAL INFROMATION SUPPLEMENTAL INFROMATION SUPPLEMENTAL EXPERIMENTAL PROCEDURES IP 1 accumulation - IP 1 accumulation was quantified using the HTRF IP-One kit (Cisbio Bioassys, Bedford, MA, USA) according to the manufacturer

More information

Mouse SerpinF2 ELISA Pair Set

Mouse SerpinF2 ELISA Pair Set Mouse SerpinF2 ELISA Pair Set Catalog Number : SEK50167 To achieve the best assay results, this manual must be read carefully before using this product and the assay is run as summarized in the General

More information

Human IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit

Human IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit Human IFN-α (Interferon-Alpha) Pre-Coated ELISA Kit Catalog No: 90-2235 1 96 well Format (96 tests) Detection Range: 15.6 1000 pg/ml Sensitivity:

More information

Data Sheet ICOS/NFAT Reporter-Jurkat Recombinant Cell Line Catalog #: 79668

Data Sheet ICOS/NFAT Reporter-Jurkat Recombinant Cell Line Catalog #: 79668 Data Sheet ICOS/NFAT Reporter-Jurkat Recombinant Cell Line Catalog #: 79668 Product Description Recombinant Jurkat T cell expressing firefly luciferase gene under the control of NFAT response elements

More information

Porcine IL-12/IL-23 p40 ELISA kit

Porcine IL-12/IL-23 p40 ELISA kit Porcine IL-12/IL-23 p40 ELISA kit Catalog number: NB-E50014 (96 wells) The kit is designed to quantitatively detect the levels of Porcine IL-12/IL-23 p40 in cell culture supernatants. FOR RESEARCH USE

More information

Application Note AN001

Application Note AN001 Testing hybridoma supernatants with the Spots On Dots Antibody Screening Kit Application Note AN1 Table of Contents Overview... 2 Figure 1. Screening of hybridomas raised against peptide antigens... 3

More information

special offers from your protein biology resource

special offers from your protein biology resource special offers from your protein biology resource Pop open your cells, extract your proteins, purify, quantify and express them. Seeking knowledge about proteins with Thermo Scientific Protein Research

More information

Mitochondria/Cytosol Fractionation Kit

Mitochondria/Cytosol Fractionation Kit Mitochondria/Cytosol Fractionation Kit Sufficient for analysis of 50 samples Cat. No. MIT1000 FOR RESEARCH USE ONLY Not for use in diagnostic procedures. USA & Canada Phone: +1(800) 437-7500 Fax: +1 (951)

More information

Data Sheet. TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536

Data Sheet. TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536 Data Sheet TCR activator / PD-L1 - CHO Recombinant Cell line Cat. #: 60536 Product Description Recombinant CHO-K1 cells constitutively expressing human PD-L1 (Programmed Cell Death 1 Ligand 1, CD274, B7

More information

AAV Purification Maxi Slurry Kit Product # 63250

AAV Purification Maxi Slurry Kit Product # 63250 3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com AAV Purification Maxi Slurry Kit Product # 63250 Product Insert

More information

isolated from ctr and pictreated mice. Activation of effector CD4 +

isolated from ctr and pictreated mice. Activation of effector CD4 + Supplementary Figure 1 Bystander inflammation conditioned T reg cells have normal functional suppressive activity and ex vivo phenotype. WT Balb/c mice were treated with polyi:c (pic) or PBS (ctr) via

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Veterinary Use CVMP/IWP/07/98-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES

More information

CCL1 (Human) ELISA Kit

CCL1 (Human) ELISA Kit CCL1 (Human) ELISA Kit Catalog Number KA1725 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Principle of the Assay... 3 General Information... 4

More information

Anti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase. Product no: C2-HRP

Anti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase. Product no: C2-HRP Anti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase Product no: C2-HRP Product Description This monoclonal antibody (Mab) reacts with Asian Sea bass (Lates

More information

Data Sheet. Hedgehog Signaling Pathway Gli Reporter NIH3T3 Cell Line Catalog #: 60409

Data Sheet. Hedgehog Signaling Pathway Gli Reporter NIH3T3 Cell Line Catalog #: 60409 Data Sheet Hedgehog Signaling Pathway Gli Reporter NIH3T3 Cell Line Catalog #: 60409 Product Description The Gli Reporter NIH3T3 Cell Line is designed for monitoring the activity of the hedgehog signaling

More information

Androgen Receptor (Phospho-Tyr363) Colorimetric Cell-Based ELISA Kit. Catalog #: OKAG02138

Androgen Receptor (Phospho-Tyr363) Colorimetric Cell-Based ELISA Kit. Catalog #: OKAG02138 Androgen Receptor (Phospho-Tyr363) Colorimetric Cell-Based ELISA Kit Catalog #: OKAG02138 Please read the provided manual entirely prior to use as suggested experimental protocols may have changed. Research

More information